This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1988:66:85-93.

Dose-related effects of recombinant human erythropoietin on erythropoiesis. Results of a multicenter trial in patients with end-stage renal disease

J Bommer¹, M Kugel, W Schoeppe, R Brunkhorst, W Samtleben, P Bramsiepe, P Scigalla

Affiliations

PMID: 3292151

Clinical Trial

Dose-related effects of recombinant human erythropoietin on erythropoiesis. Results of a multicenter trial in patients with end-stage renal disease

J Bommer et al. Contrib Nephrol. 1988.

. 1988:66:85-93.

Authors

J Bommer¹, M Kugel, W Schoeppe, R Brunkhorst, W Samtleben, P Bramsiepe, P Scigalla

Affiliation

¹ Medical Clinic, University of Heidelberg, FRG.

PMID: 3292151

No abstract available

PubMed Disclaimer

Similar articles

Analysis of initial resistance of erythropoiesis to treatment with recombinant human erythropoietin. Results of a multicenter trial in patients with end-stage renal disease.
Kühn K, Nonnast-Daniel B, Grützmacher P, Grüner J, Pfåffl W, Baldamus CA, Scigalla P. Kühn K, et al. Contrib Nephrol. 1988;66:94-103. Contrib Nephrol. 1988. PMID: 3292152 Clinical Trial. No abstract available.
Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.
Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Eschbach JW, et al. N Engl J Med. 1987 Jan 8;316(2):73-8. doi: 10.1056/NEJM198701083160203. N Engl J Med. 1987. PMID: 3537801 Clinical Trial.
Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
Sobota JT. Sobota JT. Contrib Nephrol. 1989;76:166-78; discussion 212-8. Contrib Nephrol. 1989. PMID: 2684519 Clinical Trial. No abstract available.
Erythropoietin therapy in patients with chronic renal failure.
Pinevich AJ, Petersen J. Pinevich AJ, et al. West J Med. 1992 Aug;157(2):154-7. West J Med. 1992. PMID: 1441466 Free PMC article. Review.
Management of the anaemia of chronic renal failure with recombinant erythropoietin.
Adamson JW, Eschbach JW. Adamson JW, et al. Q J Med. 1989 Dec;73(272):1093-101. Q J Med. 1989. PMID: 2694210 Review. No abstract available.

See all similar articles

Cited by

Recombinant human epoetin beta in the treatment of renal anemia.
Locatelli F, Pozzoni P, Vecchio LD. Locatelli F, et al. Ther Clin Risk Manag. 2007 Jun;3(3):433-9. Ther Clin Risk Manag. 2007. PMID: 18488073 Free PMC article.
[Erythropoietin and hypertension].
Frei U, Nonnast-Daniel B, Koch KM. Frei U, et al. Klin Wochenschr. 1988 Sep 15;66(18):914-9. doi: 10.1007/BF01728954. Klin Wochenschr. 1988. PMID: 3054276 Review. German.
Treatment of the anaemia of chronic renal failure with recombinant human erythropoietin.
Winearls CG. Winearls CG. Drugs. 1989 Sep;38(3):342-5. doi: 10.2165/00003495-198938030-00002. Drugs. 1989. PMID: 2806134 No abstract available.
Epoetin (recombinant human erythropoietin). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in anaemia and the stimulation of erythropoiesis.
Faulds D, Sorkin EM. Faulds D, et al. Drugs. 1989 Dec;38(6):863-99. doi: 10.2165/00003495-198938060-00004. Drugs. 1989. PMID: 2693045 Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information